Validation of TIMI Risk Score for STEMI

Silveira, Daniel Souto; Jaeger, Cristiano Pederneiras; Hatschbach, Luciano; Manenti, Euler Roberto Fernandes

doi:10.5935/2359-4802.20160034

Cited by 10 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In many previous studies TIMI risk score has been shown to be reliable predictor of in-hospital and 30 days mortality. In a retrospective cohort study in Brazil by Silveira et al 13 , 22.6% populations in the age group of 65 to 74 years and 13.2% were 75 years and above. Two third (66.6%) of cases were male.…”

Section: Discussionmentioning

confidence: 94%

Validation of TIMI risk score for STEMI patients visiting a tertiary care hospital of western Nepal

2022

View full text Add to dashboard Cite

Introduction: Cardiovascular disease is the leading cause of death globally, and ST elevation myocardial infarction remains main contributor to this mortality. Thrombolysis in myocardial infarction risk score which was derived from randomized clinical trials has been validated in non-selected western patient populations. The objective of this study was to find out the applicability of Thrombolysis in myocardial infarction risk score in our study population. Methods: A prospective observational study was conducted in admitted patients of cardiology unit, Manipal teaching hospital from February 25, 2020 to December 31, 2021. All consecutive patients admitted with diagnosis of acute ST elevation myocardial infarction were selected. Patients admitted with diagnosis of ST segment elevation myocardial infarction and undergone either primary, rescue or elective coronary reperfusion therapy were included for analysis. Results: Total of 339 cases with mean age of 60.62 ±12.64 were diagnosed to have acute ST elevation myocardial infarction and undergone coronary reperfusion therapy. Nearly two third cases were male and majority (61.35%) cases were below age of 65 years. Age of 65 years and above, Killip class III-IV [OR:20.54 (CI: 8.63–48.87), p<0.001], low HDL [(OR:0.481 (CI: 0.23 – 0.97) p= 0.038], heart rate >100 beats/ min [(OR: 5.79 (CI: 2.81 – 11.92), p<0.001] and anterior wall involvement [(OR: 2.8 (CI: 1.39–6.41), p=0.004] were significantly associated with 30 days mortality. Conclusions: Thrombolysis in myocardial infarction risk score is applicable in clinical practice for better risk stratified treatment in our setting.

show abstract

Section: Discussionmentioning

confidence: 94%

Validation of TIMI risk score for STEMI patients visiting a tertiary care hospital of western Nepal

2022

View full text Add to dashboard Cite

show abstract

“…Furthermore, a large external data in STEMI patients has been performed well with the TIMI risk score. 6 In patients who undergo primary percutaneous coronary intervention (PCI), however, the clinical relevance of RV dysfunction in that currently growing population of post-AMI patients is unknown. Therefore, the aim of the current study was to investigate the relationship between RV function measured by TAPSE with time to revascularization and 30 days of mortality in patients treated with primary PCI.…”

Section: Introductionmentioning

confidence: 99%

Correlation between Right Ventricular Function with Revascularization Time and 30-day Mortality in ST-Elevation Myocardial Infarction Patients Underwent Right Coronary Artery Intervention

Luntungan

Djafar

Panda

et al. 2022

eCL

View full text Add to dashboard Cite

Abstracts: Right ventricular (RV) function provides strong prognostic information in patients treated with primary percutaneous coronary intervention (PCI) due to myocardial infarction. Longitudinal RV systolic function can be assessed by the measurement of the tricuspid annular plane systolic excursion (TAPSE). This study aimed to evaluate the correlation between TAPSE and revascularization time with 30-day mortality using TIMI risk score in patients presenting STEMI who underwent revascularization of right coronary artery (RCA). This was a descriptive amd analytical study. Data were collected from iSTEMI Registry database which consisted of 49 STEMI patients undergoing PCI in RCA and TAPSE measurement at Prof. Dr. R. D. Kandou General Hospital from October 3rd, 2018 to July 28th, 2019. Echocardiographic examination was done within 48 hours of hospitalization. A descriptive analysis and bivariate correlation with Spearman’s rho were applied between given variables. P-value of <0.05 was considered to be statistically significant. The results showed that the mean age of the patients was 57.92 10.345 years old and 79.2% were male. The mean TAPSE measurement was 18.51 mm +/- 3.63 mm. The median revascularization time was 357.5 minutes while median TIMI score was 4. Shorter treatment time (p=0.708) and lower TIMI score (p=0.923) were not associated with better right ventricular function measured with TAPSE in patients undergoing RCA intervention. In conclusion, right ventricular function is not associated with revascularization time and thirty days mortality in patients presenting with ST-elevation acute myocardial infarction involving right coronary artery.Keywords: tricuspid annular plane systolic excursion; revascularization time; right coronary artery; ST-elevation myocardial infarction

show abstract

“…A Doença cardiovascular é uma das principais causas de morte em populações ocidentais perfazendo 16% dos óbitos em países desenvolvidos (SILVEIRA et al, 2016 et al, 2016).…”

Section: Introductionunclassified

Conversão De Energia Em Sistemas Fotovoltaicos Conectados À Rede Elétrica

Melquiares¹,

Neto²

2021

A Plurivalência Da Engenharia Da Computação E Seu Amplo Campo De Aplicação

View full text Add to dashboard Cite

Direitos para esta edição cedidos à Atena Editora pelos autores. Todo o conteúdo deste livro está licenciado sob uma Licença de Atribuição Creative Commons. Atribuição-Não-Comercial-NãoDerivativos 4.0 Internacional (CC BY-NC-ND 4.0).O conteúdo dos artigos e seus dados em sua forma, correção e confiabilidade são de responsabilidade exclusiva dos autores, inclusive não representam necessariamente a posição oficial da Atena Editora. Permitido o download da obra e o compartilhamento desde que sejam atribuídos créditos aos autores, mas sem a possibilidade de alterá-la de nenhuma forma ou utilizá-la para fins comerciais. Todos os manuscritos foram previamente submetidos à avaliação cega pelos pares, membros do Conselho Editorial desta Editora, tendo sido aprovados para a publicação com base em critérios de neutralidade e imparcialidade acadêmica.A Atena Editora é comprometida em garantir a integridade editorial em todas as etapas do processo de publicação, evitando plágio, dados ou resultados fraudulentos e impedindo que interesses financeiros comprometam os padrões éticos da publicação. Situações suspeitas de má conduta científica serão investigadas sob o mais alto padrão de rigor acadêmico e ético.

show abstract

Validation of TIMI Risk Score for STEMI

Cited by 10 publications

References 0 publications

Validation of TIMI risk score for STEMI patients visiting a tertiary care hospital of western Nepal

Validation of TIMI risk score for STEMI patients visiting a tertiary care hospital of western Nepal

Correlation between Right Ventricular Function with Revascularization Time and 30-day Mortality in ST-Elevation Myocardial Infarction Patients Underwent Right Coronary Artery Intervention

Conversão De Energia Em Sistemas Fotovoltaicos Conectados À Rede Elétrica

Contact Info

Product

Resources

About